Evidence map›Paper›PMID 34884852›Full record

ArticleInternational journal of molecular sciences2021

Genome-Wide Mutation Scoring for Machine-Learning-Based Antimicrobial Resistance Prediction.

Peter Májek, Lukas Lüftinger, Stephan Beisken, Thomas Rattei, Arne Materna

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Evaluating the Performance ofCombinatorial chemistry & high throughput screening · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peter MájekAres Genetics GmbH, Vienna 1030, Austria.
Lukas LüftingerAres Genetics GmbH, Vienna 1030, Austria.ORCID 0000-0002-5997-8236
Stephan BeiskenAres Genetics GmbH, Vienna 1030, Austria.
Thomas RatteiCentre for Microbiology and Environmental Systems Science, Division of Computational Systems Biology, University of Vienna, Vienna 1030, Austria.ORCID 0000-0002-0592-7791
Arne MaternaAres Genetics GmbH, Vienna 1030, Austria.

Funding

Vienna Business Agency 24478239
6 · The paper itself

Abstract

The prediction of antimicrobial resistance (AMR) based on genomic information can improve patient outcomes. Genetic mechanisms have been shown to explain AMR with accuracies in line with standard microbiology laboratory testing. To translate genetic mechanisms into phenotypic AMR, machine learning has been successfully applied. AMR machine learning models typically use nucleotide k-mer counts to represent genomic sequences. While k-mer representation efficiently captures sequence variation, it also results in high-dimensional and sparse data. With limited training data available, achieving acceptable model performance or model interpretability is challenging. In this study, we explore the utility of feature engineering with several biologically relevant signals. We propose to predict the functional impact of observed mutations with PROVEAN to use the predicted impact as a new feature for each protein in an organism's proteome. The addition of the new features was tested on a total of 19,521 isolates across nine clinically relevant pathogens and 30 different antibiotics. The new features significantly improved the predictive performance of trained AMR models for

Indexed as

Machine LearningAnti-Infective AgentsDrug Resistance, BacterialEscherichia coliGenome, BacterialGenomicsMutationPseudomonas aeruginosaWhole Genome SequencingAnti-Infective Agentsantibioticsantimicrobial resistancegenome-wide mutation scoringgenomicsmachine learningWGS

Identifiers

PMID34884852
PMCPMC8657983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.